Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
---|
04/16/2008 | EP1911447A1 Eye drop preparation comprising xanthan gum and terpenoid |
04/16/2008 | EP1911444A1 Drug-containing coated fine particle for intrabuccally disintegrating preparation and method of producing the same |
04/16/2008 | EP1910575A2 Immunohistochemistry detection method |
04/16/2008 | EP1910407A2 Mutated pseudomonas exotoxins with reduced antigenicity |
04/16/2008 | EP1909858A2 Hydrogel |
04/16/2008 | EP1909848A2 HMGCoA REDUCTASE INHIBITOR CODRUGS AND USES THEREOF |
04/16/2008 | EP1909847A2 Polymers having covalently bound therapeutic agents |
04/16/2008 | EP1909846A2 Triazole-containing releasable linkers, conjugates thereof, and methods of preparation |
04/16/2008 | EP1909845A2 N,n-bis-(2-hydroxyethyl) glycine amide as linker in polymer conjugated prodrugs |
04/16/2008 | EP1909844A1 Topical formulations containing sporopollenin |
04/16/2008 | EP1909843A2 Antitumoral bioconjugates of hyaluronic acid or its derivatives obtained by indirect chemical conjugation, and their use in the pharmaceutical field |
04/16/2008 | EP1909842A2 Improved botulinum toxin compositions |
04/16/2008 | EP1909841A2 Vaginal treatment composition |
04/16/2008 | EP1909840A1 Medicated gauze |
04/16/2008 | EP1909839A1 Stabilizers for veterinary vaccines |
04/16/2008 | EP1909838A2 Formulations that inhibit protein aggregation |
04/16/2008 | EP1909775A2 Formulation of radioprotective alpha, beta unsaturated aryl sulfones |
04/16/2008 | EP1909772A1 Transdermal drug delivery formulation |
04/16/2008 | EP1909757A2 Oral liquid losartan compositions |
04/16/2008 | EP1909756A1 Pharmaceutical formulations of endo-n-(9- methyl-9-azabicyclo[3 .3.1]non-3-yl)-1-methyl-1h-indazole-3-carboxamide hydrochloride |
04/16/2008 | EP1909755A2 Cyclodextrin nanotechnology for ophthalmic drug delivery |
04/16/2008 | EP1909689A2 Drug-containing implants and methods of use thereof |
04/16/2008 | EP1909567A1 Modified inorganic materials |
04/16/2008 | EP1572154A4 Medical devices employing novel polymers |
04/16/2008 | EP1545563B1 Composition and method for use in intestinal cleansing procedures |
04/16/2008 | EP1534334A4 Releasable polymeric conjugates based on aliphatic biodegradable linkers |
04/16/2008 | EP1509255B1 Methods and compositions for intravesical therapy of bladder cancer |
04/16/2008 | EP1476032B1 Coenzyme q10 formulation |
04/16/2008 | EP1467771B1 Mycobacterial vaccine |
04/16/2008 | EP1401404B1 Method of encapsulating an active substance |
04/16/2008 | EP1343823B1 Antithrombotic von willebrand factor (vwf) collagen bridging blockers |
04/16/2008 | EP1250434B1 84p2a9: a prostate and testis specific protein highly expressed in prostate cancer |
04/16/2008 | EP1222289B1 Chimeric immunogenic compositions and nucleic acids encoding them |
04/16/2008 | EP1100460B1 A moldable solid delivery system |
04/16/2008 | EP1026945B1 Improved iodine antimicrobial compositions containing nonionic surfactants and halogen anions |
04/16/2008 | CN101163789A Highly porous polymeric materials comprising biologically active molecules via covalent grafting |
04/16/2008 | CN101163508A Integration of meningococcal conjugate vaccination |
04/16/2008 | CN101163507A Process for the preparation of polymer conjugates |
04/16/2008 | CN101163506A Polymer-von willebrand factor-conjugates |
04/16/2008 | CN101163500A Composition for adjuvant containing poly-gamma-glutamic acid |
04/16/2008 | CN101163486A Use of azithromycin for the production of a medicament for treatment of ocular infections |
04/16/2008 | CN101161290A Beta-elemi alkene polyglycol amine derivant as well as its synthesis method and purpose |
04/16/2008 | CN101161289A Water-solubility carrier |
04/16/2008 | CN101161257A Corydalis total alkali clathrate, its preparing method and application |
04/16/2008 | CN101161250A A novel enteron pharmaceutical preparation and its preparing method |
04/16/2008 | CN101161247A Potassium muriate stomach-inner retention floationg type slow release tablet prepared with shuck powder as carrier |
04/16/2008 | CN101161244A Nimodipine tablet and its preparing method |
04/16/2008 | CN101161242A A explosive core composition of controlled release administer drug and controlled release preparation as well as its preparing method |
04/16/2008 | CN101161241A Technique of preparing amlodipine besylate tablets |
04/16/2008 | CN101161239A PLGA Gemcitabine sustained-release microsphere and its preparing method |
04/16/2008 | CN101161238A A lipid nanometer microcapsule based on phospholipids and method for preparing the same |
04/16/2008 | CN101161237A Steady cisplatin element lipoid plastid and method for preparing the same |
04/16/2008 | CN101161236A Method of producing drug-carrying nanometer particle of duplicate flocculation technics in microemulsion |
04/16/2008 | CN101161235A Dasatini sustained-release implants for treating entity knub |
04/16/2008 | CN101161234A Erlotinib sustained-release implants for treating entity knub |
04/16/2008 | CN101161228A Solid cosmetic and therapeutic compositions applicable to the human skin and gellable on contact with water |
04/16/2008 | CN100381454C Crystalline form of a ribofuranosyluronamide derivative: a human adenosine a2a receptor agonist |
04/16/2008 | CN100381175C Microemulsion formulation and its preparation process |
04/16/2008 | CN100381173C Antitumor agents comprising a targeting portion and an immune response triggering portion |
04/16/2008 | CN100381172C Treating prostate cancer with anti-ErbB2 antibodies |
04/16/2008 | CN100381117C Edible coating composition |
04/15/2008 | US7358379 Steroid conjugates, preparation thereof and the use thereof |
04/15/2008 | US7358284 Particulate acellular tissue matrix |
04/15/2008 | US7358226 The localized, targeted delivery of a drug or contrast agent for imaging by administering and concentrating a carrier by exposing it to a radiation force generated by ultrasound waves at a frequency and pressure combination; rupturing;affecting tissue permeability or altering cell physiology |
04/15/2008 | US7357949 Microcapsule with average diameter of </= 2000 mu; inorganic antimicrobial agent encapsulated within a hydrophilic polymer |
04/15/2008 | US7357948 Controlled release ceramic particles, compositions thereof, processes of preparation and methods of use |
04/15/2008 | US7357946 Uses for cellulose-containing aggregates |
04/15/2008 | US7357944 Liposomal analgesic drug compositions prepared in GMV using an ammonium sulfate gradient |
04/15/2008 | US7357943 Pharmaceutical preparation in the form of a suspension comprising an acid-labile active ingredient |
04/15/2008 | US7357941 implanting matrix for bioactive material which is biocompatible porous forms of beta -tricalcium phosphate granules support the development of new bone throughout its structural form, together with bone morphogenic protein as bioactive material |
04/15/2008 | US7357936 immunostimulant (3-de-O-acylated monophosphoryl lipid A) adsorbed onto metallic salt (aluminium hydroxide or aluminium phosphate); second salt with antigen which elicits immune response to polypeptide or pathogen; Hepatitis, human papilloma virus |
04/15/2008 | US7357930 Methods and formulations for targeting infectious agents bearing host cell proteins |
04/15/2008 | US7357925 Method for treating disorders and diseases treatable with human fibroblast interferon |
04/15/2008 | US7357922 Microemulsion containing alkanolammonium salts of fatty alcohol sulfates and/or alkylpolyalkyleneglycoethersulfates |
04/15/2008 | US7357336 Generation of therapeutic microfoam |
04/15/2008 | CA2566590C Cronotherapeutic diltiazem formulation and the administration thereof |
04/15/2008 | CA2454027C Residual solvent extraction method and microparticles produced thereby |
04/15/2008 | CA2401910C Hydrophilic molecular disperse solutions of carvedilol |
04/15/2008 | CA2280629C Carotenoid formulations, comprising a mixture of .beta.-carotene, lycopene and lutein |
04/15/2008 | CA2269655C Peptide compositions with growth factor-like activity |
04/15/2008 | CA2215800C Self-emulsifying formulation producing a positively charged emulsion |
04/10/2008 | WO2008043081A2 Liquid chalcogenide compositions and methods of manufacturing and using the same |
04/10/2008 | WO2008042619A2 Self-preserved aqueous pharmaceutical compositions |
04/10/2008 | WO2008042436A2 Biomarkers and assays for the treatment of cancer |
04/10/2008 | WO2008042218A1 Formulations containing an ionic mineral-ion exchange resin complex and uses thereof |
04/10/2008 | WO2008041774A1 Sustained-release preparation having bone conduction ability |
04/10/2008 | WO2008041740A1 Glutathione preparation and method for production thereof |
04/10/2008 | WO2008041704A1 Controlled release preparation |
04/10/2008 | WO2008041553A1 Tacrolimus sustained-release preparation |
04/10/2008 | WO2008041514A1 Radiation sensitizer or anti-cancer chemotherapy sensitizer |
04/10/2008 | WO2008041246A2 Injectable depot composition and its' process of preparation |
04/10/2008 | WO2008041245A2 Injectable depot composition and it's process of preparation |
04/10/2008 | WO2008040786A1 Comb polymers and use thereof for the production of active or effective ingredient formulations |
04/10/2008 | WO2008040763A1 Pharmaceutical compositions comprising bisphosphonates |
04/10/2008 | WO2008040556A1 Dried reconstituted vesicle formation for pharmaceutical application |
04/10/2008 | WO2008040362A2 Generation of a cancer-specific immune response toward muc1 and cancer specific muc1 antibodies |
04/10/2008 | WO2008040230A1 Consolidant for trauma and ulcer comprising fibronectin |
04/10/2008 | WO2008023378A9 Conjugates of rgd peptides and porphyrin or (bacterio)chlorophyll photosynthesizers and their uses |
04/10/2008 | WO2008019254A3 Reagents, methods and systems to suppress pro-inflammatory cytokines |
04/10/2008 | WO2008016701A3 Biogenic silica from silica-containing plant material such as rice hulls |